Maximum Dose of Progesterone for Hormone Replacement Therapy
For endometrial protection in HRT, the maximum recommended dose of micronized progesterone is 200 mg daily for continuous regimens or 200 mg daily for 12-14 days per month in sequential regimens. 1
Standard Dosing Regimens
Sequential (Cyclic) Administration
- Micronized progesterone: 100-200 mg daily for 10-14 days per month provides adequate endometrial protection when combined with continuous estrogen therapy 1, 2
- The 200 mg dose represents the upper limit for standard sequential therapy and has been validated in clinical trials for up to 3 years of treatment 3
- Sequential regimens typically induce withdrawal bleeding, which occurs in approximately 73-80% of women 3
Continuous Combined Administration
- Micronized progesterone: 100 mg daily when administered continuously with estrogen 1
- This lower continuous dose provides endometrial protection while potentially reducing side effects compared to higher doses 1
Evidence from Clinical Trials
The FDA-approved dosing is based on a pivotal 3-year randomized controlled trial where progesterone capsules 200 mg daily for 12 days per 28-day cycle combined with conjugated estrogens 0.625 mg demonstrated only 6% incidence of endometrial hyperplasia versus 64% with estrogen alone 3
Alternative Routes and Higher Doses
Vaginal Administration
- Vaginal micronized progesterone: 200 mg daily for 12-14 days per month achieves adequate endometrial protection with potentially fewer systemic side effects 1, 4
- Vaginal administration may be preferred when oral progestins cause intolerable side effects 1
Rectal Administration
- Rectal progesterone: 400 mg twice daily (800 mg total) has been studied as rescue therapy in specific fertility contexts, but this exceeds standard HRT dosing 5
- This route is not routinely recommended for standard HRT 1
Higher Oral Doses for Secondary Amenorrhea
- Progesterone 300-400 mg daily for 10 days has been studied specifically for inducing withdrawal bleeding in women with secondary amenorrhea 3
- The 400 mg dose induced complete secretory transformation in 45% of estrogen-primed postmenopausal women 3
- However, these higher doses are for specific indications, not routine HRT endometrial protection 3
Dose-Response Relationship
Research demonstrates a clear dose-dependent effect on endometrial transformation. A 1983 study showed that progesterone 300 mg daily achieved responses approaching physiological range, while lower doses (100-200 mg) produced suboptimal effects 6. However, for standard HRT endometrial protection, the 200 mg dose remains the established maximum 1, 2.
Safety Considerations
Micronized progesterone is the preferred progestin for HRT due to its superior safety profile compared to synthetic progestins, with lower risks of cardiovascular disease and venous thromboembolism 4, 2. The European Society of Human Reproduction and Embryology specifically recommends micronized progesterone as first-line therapy 4, 2.
Common Pitfalls to Avoid
- Do not exceed 200 mg daily in sequential regimens without specific clinical indication, as this is the validated maximum for endometrial protection 1, 3
- Ensure adequate duration: Sequential regimens require at least 10-12 days per month, with 12-14 days preferred for optimal endometrial protection 1, 4, 7, 2
- Do not use FSH levels to monitor adequacy of hormone replacement therapy, as this is inappropriate 1
- Avoid custom-compounded progesterone preparations lacking FDA oversight and validated endometrial protection data 7
Body Mass Index Considerations
Higher BMI may require dose adjustments, as serum progesterone levels correlate with both dose and body weight 8. However, the standard maximum doses (100-200 mg) remain the guideline-recommended limits regardless of BMI 1.